Actiphage Could Provide ‘Test of Cure’ for New TB Drugs
Actiphage has the potential to provide a reliable test of cure for new tuberculosis drugs, according to recent research.
Category: Tuberculosis
Tuberculosis
Latest
Tuberculosis
Latest
Thermo Fisher, NanoPin Collaborate to Develop Analytical Workflow for Infectious Disease Diagnosis and Patient Monitoring
NanoPin’s diagnostic platform using Thermo Fisher’s advanced LC-MS technology will create sensitive clinical assays for infectious disease.
Tuberculosis
Latest
Researchers Discover Causative Genetic Mutations in Patients with Familial Sarcoidosis
Study data show that the metabolic sensor mTOR contributes on the genetic level to the development of sarcoidosis.
Critical Path Institute Receives Grant to Accelerate Tuberculosis Diagnostics
A multiyear grant from the Bill & Melinda Gates Foundation will fund an innovative global data platform designed to streamline tuberculosis diagnosis and treatment.
Read More
FDA Approves Cepheid’s Rapid TB Test
Results are available to clinicians in approximately 2 hours.
Read More
NanoLogix Rapid TB Detection Results Published In Journal
Third-party R&D lab achieves 5-day tuberculosis detection, compared to weeks for standard tests.
Read MoreNEJM Reports Xpert MTB/RIF Faster, Sensitive & Specific Test for TB
Cepheid announced that its Xpert MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), “Rapid Molecular Detection of Tuberculosis and Rifampin Resistance.”
Read MoreNew Blood-Based Genomic Marker for Tuberculosis May Help ID Future Patients
It may soon be possible to identify patients who will develop tuberculosis, as scientists have identified changes in the blood specific to the disease.
Read MoreSeegene Introduces Real-time Molecular Diagnostic Test for Tuberculosis
Seegene introduced Anyplex MDR-TB Screening Test, the first real-time PCR molecular diagnostic capable of simultaneous detection of TB and genetic mutations leading to multi-drug resistant TB (MDR-TB) within four hours.
Read MoreNew Guidelines Prefer Blood Tests to Diagnose Tuberculosis Infection in Certain Populations
Today the United States Centers for Disease Control and Prevention (CDC) issued new and important guidelines on the detection of Mycobacterium tuberculosis infections, the causative agent of tuberculosis (TB).
Read MoreNew BD BACTEC MGIT 320 System Expands TB Detection Worldwide
BD Diagnostics announced the launch of the BD BACTEC MGIT 320 Mycobacteria Culture Systema new, smaller capacity system to quickly and accurately detect tuberculosis (TB).
Read MoreBlood Tests Demonstrate Superior Accuracy in Diagnosing Tuberculosis
New data demonstrate that Interferon Gamma Release Assays (IGRAs) are superior to the previous standard in diagnostics, the 100+-year-old tuberculin skin test (TST), for detecting confirmed active Tuberculosis (TB) disease.
Read MoreTyrian Diagnostics, BD to End TB Test Collaboration
Tyrian Diagnostics Limited announced today that Tyrian and BD will not continue their collaboration to develop a Point-of-Care (PoC) test for the diagnosis of active tuberculosis (TB).
Read More
Tuberculosis Diagnostics
Diagnosing One of the World’s Deadliest Diseases
Read More